EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSTRUG00000011645
Gene Symbol: ERBB3
4 Cross references
211 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSTRUG00000008503
Gene Symbol: ERBB4
4 Cross references
47 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSTRUG00000014636
Gene Symbol: ERBB4
3 Cross references
230 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSTRUG00000025100
Gene Symbol: ESR1
1 Cross references
215 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSTRUG00000013709
Gene Symbol: LOC101076140
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSTRUG00000006761
Gene Symbol: LOC101075495
3 Cross references
210 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSTRUG00000001481
Gene Symbol: ESRRG
3 Cross references
198 Possible Orthologues:

Exportin 1

Ensembl ID : ENSTRUG00000027000
Gene Symbol: XPO1
1 Cross references
211 Possible Orthologues:

Exportin 1

Ensembl ID : ENSTRUG00000033434
Gene Symbol: XPO1
2 Cross references
211 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSTRUG00000022938
Gene Symbol: FDPS
3 Cross references
267 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSTRUG00000012217
Gene Symbol: FDFT1
3 Cross references
220 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSTRUG00000007691
Gene Symbol: FNTA
3 Cross references
221 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).